Richard Bergenstal, MD

Richard Bergenstal, MD

Executive Director
International Diabetes Center- Park Nicollet
Minneapolis, MN, USA

Related Videos

Evolving Accuracy of Sensor-Based CGM<br><sub>Implications for Interpretation of Ambulatory Glucose Profiles (AGPs) and Time in Range Across the Full Spectrum of Persons with Diabetes</sub> Video

Evolving Accuracy of Sensor-Based CGM
Implications for Interpretation of Ambulatory Glucose Profiles (AGPs) and Time in Range Across the Full Spectrum of Persons with Diabetes

Why Use Continuous Glucose Monitoring to Improve Diabetes Management in Primary Care? Video

Why Use Continuous Glucose Monitoring to Improve Diabetes Management in Primary Care?

Translating Guidelines, Meta-Analysis, and Real World Trials to Guide Practical Aspects of Diabetes Care in the Managed Care/HMO Setting - Richard Bergenstal, MD Video

Translating Guidelines, Meta-Analysis, and Real World Trials to Guide Practical Aspects of Diabetes Care in the Managed Care/HMO Setting - Richard Bergenstal, MD

Interpretation of Sensor-Based Glucose Metrics, Time in Range (TIR) and Ambulatory Glucose Profiles (AGP) - Module&nbsp;1 - ANALYZE Video

Interpretation of Sensor-Based Glucose Metrics, Time in Range (TIR) and Ambulatory Glucose Profiles (AGP) - Module 1 - ANALYZE

The evidence and guideline-based rationale for employing sensor-based glucose monitoring (CGM) and ambulatory glucose profiles (AGP) as a foundational strategy for managing patients with diabetes.

Interpretation of Sensor-Based Glucose Metrics, Time in Range (TIR) and Ambulatory Glucose Profiles (AGP) - Module&nbsp;2 - PERSONALIZE Video

Interpretation of Sensor-Based Glucose Metrics, Time in Range (TIR) and Ambulatory Glucose Profiles (AGP) - Module 2 - PERSONALIZE

Understanding an AGP report: What are the clinical implications of Time in Range (TIR) and the Glucose Management Indicator (GMI), and how should the clinician approach specific glucose metrics on the AGP to optimize diabetes management?

Interpretation of Sensor-Based Glucose Metrics, Time in Range (TIR) and Ambulatory Glucose Profiles (AGP) - Module&nbsp;3 - ACT Video

Interpretation of Sensor-Based Glucose Metrics, Time in Range (TIR) and Ambulatory Glucose Profiles (AGP) - Module 3 - ACT

Translating AGP glucose metrics (TIR, GMI) into action steps and interventions at the front lines of care for persons with Type 2 or Type 1 diabetes: practical, patient-centric roadmap.

Case-Based, Real World Applications of Sensor-Based CGM to the Front Lines of Diabetes Care Video

Case-Based, Real World Applications of Sensor-Based CGM to the Front Lines of Diabetes Care

The Faculty Discuss, Analyze, and Provide Expert-Based Consultation for How to Interpret AGP Reports and Make Therapeutic Decisions in Persons with Type 2 and Type 1 Diabetes

Interactive Q&A Session Video

Interactive Q&A Session

The Evolving and Foundational Role of Personalized HA1c to Optimize Management of Diabetes Video

The Evolving and Foundational Role of Personalized HA1c to Optimize Management of Diabetes

The Use of Ambulatory Glucose Profiling (AGP) to Optimize Clinical Outcomes—New Consensus-Based Guidance Supporting CGM Across the Spectrum of Diabetes Care